Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal?

Korn, Edward L

Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal? [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research 05 2018 - 2239-2240 p. digital

Publication Type: Journal Article; Comment

1557-3265

10.1158/1078-0432.CCR-18-0183 doi


Biomarkers
Goals
Humans
Immunologic Factors
Immunotherapy
Progression-Free Survival